The first U.S. patient to participate in a global study of a stem cell therapy…
View More First US patient in novel stem cell trial for stroke disability enrolled at UTHealth
Early treatment, baseline mental health are predictors of quality of life following radiosurgery for brain metastasis
Clinical researchers who study tumors that have metastasized to the brain have frequently asked, “How…
View More Early treatment, baseline mental health are predictors of quality of life following radiosurgery for brain metastasis
Study points to alternate therapy for rare form of diabetes
Vanderbilt University Medical Center researchers say an unexpected finding during the cellular analysis of human…
View More Study points to alternate therapy for rare form of diabetes
I Didn’t Know Getting My First Period at 10 Was a Red Flag for Endometriosis
I was taping Duran Duran photos to my friend’s wall after school when I felt…
View More I Didn’t Know Getting My First Period at 10 Was a Red Flag for Endometriosis
Vaccines: Not Just for Kids
MONDAY, Jan. 14, 2019 — If you have children, you know how important it is…
View More Vaccines: Not Just for Kids
Diane Kruger Demands Respect For Baby's Privacy After Photo Leak
Diane Kruger and Norman Reedus recently welcomed their first child, and while the pair has…
View More Diane Kruger Demands Respect For Baby's Privacy After Photo Leak
Trying Whole30 Diet? Watch Out for Weight Regain
MONDAY, Jan. 7, 2019 — Thinking of eating healthier in 2019? Kickstarting with the Whole30…
View More Trying Whole30 Diet? Watch Out for Weight Regain
Moderate Drinking Not Harmful for Seniors With Heart Failure
THURSDAY, Jan. 3, 2019 — For older adults with heart failure, limited alcohol consumption after…
View More Moderate Drinking Not Harmful for Seniors With Heart Failure
Loxo Oncology Announces Initiation of Phase 1/2 Clinical Trial for Highly Selective, Non-Covalent BTK Inhibitor, LOXO-305
STAMFORD, Conn., Dec. 21, 2018 (GLOBE NEWSWIRE) — Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company…
View More Loxo Oncology Announces Initiation of Phase 1/2 Clinical Trial for Highly Selective, Non-Covalent BTK Inhibitor, LOXO-305
Kansas man getting Christmas wish for '2 front teeth' after present-wrapping disaster
Kansas man to actually receive two front teeth for Christmas A Kansas man who lost…
View More Kansas man getting Christmas wish for '2 front teeth' after present-wrapping disaster